Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 37.93
Day High 38.39
Open:38.01
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports+

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Pain Relief Therapy Market Is Projected To Witness Vigorous Expansion By 2026 | Johnson & Johnson Services, Inc., Eli Lilly & Company, Merck & Co. Inc., Pfizer, Inc., Abbott, F. Hoffmann La Roche Ltd., DJO, LLC, Breg, Inc., Beiersdorf AG
- GlobeNewswire - Fri Aug 14, 6:52AM CDT
GlobeNewswire - CMTX
Fri Aug 14, 6:52AM CDT
Databridgemarketresearch.com announces the release of the report "Global Pain Relief Therapy Market" Size, Share & Trends Analysis Report By 2026. Market research report such as Global Pain Relief Therapy report proves to be an ideal solution when it comes to a better understanding of the chemical and materials industry and lead the business growth. Market definitions, segmentation, applications, and value chain structure of this industry are all mentioned in the Global Pain Relief Therapy Market report. This Global Pain Relief Therapy Market report provides current as well as upcoming technical and financial details of the industry to 2026. According to this report, the market renovation will mainly take place due to the actions of key players or brands like developments, product launches, joint ventures, mergers, and acquisitions. The company profiles of all the key players and brands that are dominating this Global Pain Relief Therapy Market have been taken into consideration here.
ContraFect Reports Second Quarter 2020 Financial Results and Provides Business Update
- GlobeNewswire - Fri Aug 14, 6:30AM CDT
GlobeNewswire - CMTX
Fri Aug 14, 6:30AM CDT
Exebacase Phase 2 study results published in the Journal of Clinical Investigation
Europe Dietary Supplements Market Size to Hit USD 33.80 Bn by 2027; Increasing Awareness about Health and Wellness to Accelerate Market Expansion, Says Fortune Business Insights(TM)
- GlobeNewswire - Fri Aug 14, 2:10AM CDT
GlobeNewswire - CMTX
Fri Aug 14, 2:10AM CDT
The Europe dietary supplements market size is projected to reach USD 33.80 billion by 2027, exhibiting a CAGR of 9.3% during the forecast period. Rapid spread of the coronavirus across Europe has brought to the fore the importance of dietary supplements in the recent months, states Fortune Business Insights(TM) in its report, titled "Europe Dietary Supplements Market Size, Share & COVID-19 Impact Analysis, By Type (Vitamins, Minerals, Enzymes, Fatty Acids, Proteins, and Others), Form (Tablets, Capsules, Powder, and Liquid), and Regional Forecasts, 2020 - 2027".
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 35.26 +8.23% increase
on 07/16/20
Period Open:35.23
Price movement based on the high, low and last over the given period.
39.45 -3.28% decrease
on 07/29/20
+2.93 (+8.31%) increase
since 07/14/20
3-Month 31.61 +20.71% increase
on 06/26/20
Period Open:37.92
Price movement based on the high, low and last over the given period.
39.45 -3.28% decrease
on 07/29/20
+0.24 (+0.63%) increase
since 05/14/20
52-Week 27.88 +36.86% increase
on 03/23/20
Period Open:34.24
Price movement based on the high, low and last over the given period.
40.97 -6.86% decrease
on 01/24/20
+3.92 (+11.44%) increase
since 08/14/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies